Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jul 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2306651000001114 | Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2306661000001112 | Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Has AMP | Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Is a | Generic Palforzia Level 3 (12mg daily) 2 week up-dosing pack 48 capsule | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Has dispensed dose form | Dose form not applicable (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator | EMA (European Medicines Agency) monitoring | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Palforzia Level 3 (12mg daily) 2 week up-dosing pack (Aimmune Therapeutics UK Ltd) 48 capsule 16 x (1 capsule + 2 capsules) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR